BeyondSpring Inc. (NASDAQ:BYSI – Get Free Report)’s share price dropped 3.8% during trading on Wednesday . The stock traded as low as $1.46 and last traded at $1.49. Approximately 43,621 shares changed hands during mid-day trading, an increase of 23% from the average daily volume of 35,439 shares. The stock had previously closed at $1.55.
BeyondSpring Trading Down 3.8 %
The business’s fifty day simple moving average is $1.71 and its two-hundred day simple moving average is $1.87.
BeyondSpring Company Profile
BeyondSpring Inc, a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immunomodulating microtubule-binding agent that has completed Phase III clinical trials for treatment of non-small cell lung cancer (NSCLC); and as an anti-cancer agent, as well as for the prevention of chemotherapy-induced neutropenia.
Recommended Stories
- Five stocks we like better than BeyondSpring
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Energy Transfer: Powering Data With Dividends and Diversification
- What Are the FAANG Stocks and Are They Good Investments?
- Qualcomm Stock Is Coiling for a Breakout
- How to find penny stocks to invest and trade
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Receive News & Ratings for BeyondSpring Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BeyondSpring and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.jpg?v=20211124101220&h=45&w=95&zc=2){kind=logo}
